DeepSeek claims it can reduce the power consumption of AI, urging the energy industry to rethink future demand estimates.

The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease ...

DeepSeek’s recent claim that it can make artificial intelligence less power-hungry is just the latest reason the energy ...

Robert F. Kennedy Jr., the nominee to lead the Department of Health and Human Services, made disputed claims before the ...

HHS adds 15 drugs to Medicare Part D price negotiations, targeting cost reductions under the Inflation Reduction Act. New prices aim to save billions by 2027.

The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.

Michael Batnick said the outperformance of consumer discretionary stocks relative to consumer staples is "the most bullish ...

Robert F. Kennedy Jr. told the Senate Finance Committee that he is not anti-vaccine during his confirmation hearing for ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...

"Investors are questioning the long-term impact of revolutionary weight loss drugs like Ozempic on food and beverage ... and this is the chart that is giving me confidence," Batnick said in ...